CCIA
CLPT icon

Campbell & Co Investment Adviser’s ClearPoint Neuro CLPT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,433
Closed -$445K – 1160
2025
Q3 		$445K Sell
20,433
-16,822
-45% -$198K 0.03% 781
2025
Q2 		$445K Buy
+37,255
New +$469K 0.03% 827

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
FCM
FirstWave Capital Management Miami, Florida $94.1M AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Campbell & Co Investment Adviser's CLPT Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of ClearPoint Neuro (CLPT) in Q4 2025, closing a stake of 20,433 shares — an estimated $445K sold.

Campbell & Co Investment Adviser first reported a position in CLPT in Q2 2025 and held it in 2 quarters. The position peaked at $445K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining ClearPoint Neuro position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 20,433 ClearPoint Neuro shares in Q4 2025, an estimated $445K.
  • Campbell & Co Investment Adviser first reported a position in ClearPoint Neuro in Q2 2025 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's ClearPoint Neuro position peaked at $445K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.